Your session is about to expire
← Back to Search
Behavioural Intervention
Smoking Cessation App for Mental Illness
N/A
Waitlist Available
Led By Gail Daumit
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 5, week 9, and week 13
Awards & highlights
Study Summary
This trial is testing an intervention to help deliver a smoking cessation app specifically for people with mental illness who are receiving care at community mental health programs.
Who is the study for?
This trial is for regular smokers with serious mental illness (SMI) who are part of the Johns Hopkins Bayview Adult Psychiatry Program and own a smartphone. They must be willing to quit smoking. Pregnant women or those planning to become pregnant within 3 months cannot participate.Check my eligibility
What is being tested?
The study is testing a new smoking cessation app designed specifically for individuals with SMI. Participants will use this digital therapeutic tool remotely, and its effectiveness in helping them quit smoking will be evaluated.See study design
What are the potential side effects?
Since this trial involves a digital app for quitting smoking, there may not be direct side effects like with medications; however, participants might experience stress or frustration during the process of trying to quit.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 5, week 9, and week 13
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 5, week 9, and week 13
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
App Usability
Change in Self reported social support
Duration of user Interactions with the Learn to Quit (LTQ) app
+5 moreSecondary outcome measures
Smoke
Psychiatric Functioning
Trial Design
1Treatment groups
Experimental Treatment
Group I: Consumers who smoke at outpatient community mental health clinicExperimental Treatment1 Intervention
Consumers with serious mental illness who attend outpatient community mental health clinic will participate in a smoking cessation with the LTQ application and nicotine replacement therapy
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,267 Previous Clinical Trials
14,837,582 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,789 Previous Clinical Trials
2,690,405 Total Patients Enrolled
Gail DaumitPrincipal InvestigatorJohns Hopkins University
2 Previous Clinical Trials
109 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a smoker but willing to quit.I am willing to participate in the trial.You have a smartphone.I am not pregnant and do not plan to become pregnant in the next 3 months.
Research Study Groups:
This trial has the following groups:- Group 1: Consumers who smoke at outpatient community mental health clinic
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers presently accepting new participants for this exploration?
"The information found on clinicaltrials.gov affirms that this medical research is not presently taking new participants. It was originally posted to the website on January 1st 2023 and last revised October 10th 2022. Although it does not require volunteers, there are 503 other active trials needing individuals at present."
Answered by AI
Share this study with friends
Copy Link
Messenger